NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









MPC Therapeutics AG

MPC Therapeutics AG

Private
SchlierenHealthcare & Life Scienceshttps://www.mpc-therapeutics.com/

Last Round

Seed

Nov 16, 2023

Total Funding Raised

$1.74M

Company Overview

MPC Therapeutics AG is a biotechnology research company that develops a new generation of cancer therapies that modulate transcription.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Biotech Equipment

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

MPC inhibitorcell therapy enhancementsmall molecule therapeuticsCAR-T enhancementcell metabolism reprogrammingmitochondrial modulatorsex-vivo manufacturingT-cell quality enhancerstem cell memory T cellsTscmbiomanufacturingcell therapy reagentdrug discoveryneurodegenerative diseasekidney disease

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MPC Therapeutics AG Comps

Public and private peers based on sector, stage, and business model.

MPC Therapeutics AG comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

MPC Therapeutics AG Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedNov 16, 2023
SeedJan 10, 2023
View all Funding Rounds

Key People

Founding team and executive leadership

Raphaël Martinou

Co-founder & CEO

Founding Team

MPC Therapeutics AG Investors

Notable investors and investment history

MPC Therapeutics AG investors
InvestorRounds
Plutus Investment GroupSeed
FongitSeed
Venture KickAccelerator
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 2, 2025

    Monthly visitors grew 146% MoM, reaching 5.9K.

  • Dec 16, 2024

    Monthly visitors grew 213% MoM, reaching 4.7K.

View all signals

MPC Therapeutics AG Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

MPC Therapeutics AG Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about MPC Therapeutics AG's valuation, stock price, and market status.

Firmographic Details

HeadquartersSchlieren
Employee Range7
Year Founded2019
Last FundingNov 16, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.